Weekly CEO Buys Highlights

Agenus, JCPenney, Intrepid Potash, Opko Health, Seneca top list

Author's Avatar
Mar 14, 2016
Article's Main Image

According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:

Agenus: Chairman and CEO Garo H. Armen bought 200,000 shares

Agenus Inc. (AGEN, Financial) Chairman and CEOÂ Garo H. Armen bought 200,000 shares on March 7 at an average price of $4 per share. Agenus, formerly known as Antigenics Inc., was incorporated in 1994. Agenus has a market cap of $338.59 million; its shares were traded at $4 with a P/S ratio of 16.

Agenus recently announced its fourth quarter 2015 financial results. The company reported a net loss attributable to common stockholders of $15.7 million, or 18 cents per share, basic and diluted, compared with a net loss attributable to common stockholders for the fourth quarter of 2014 of $26 million, or 41 cents per share, basic and diluted.

Robert Bruce (Trades, Portfolio) owned 233,515 shares as of Dec. 31, 2014, which accounts for 0.26% of the $330 million portfolio of Bruce & Co.

CFO Charles Evan Ballantyne bought 10,000 shares on Sept. 25, 2015, at the average price of $5.05. Ballantyne owns at least 10,000 shares. The price of the stock has decreased by 20.79%.

JC Penney: CEO Marvin R. Ellison bought 50,000 shares

JCPenney Co. Inc. (JCP, Financial) CEO Marvin R. Ellison bought 50,000 shares on March 9 at an average price of $11.22. JCPenney was incorporated in Delaware on Jan. 22, 2002. JCPenney has a market cap of $3.43 billion; its shares traded at $11.22 with a P/S ratio of 0.27.

JCPenney recently announced financial results for its fiscal fourth quarter and full year ended Jan. 30. Comparable store sales grew 4.1 % for the fourth quarter and 4.5 % for the full year. This combination of strong sales growth, accelerated gross margins and disciplined expense reduction resulted in full year adjusted EBITDA of $715 million, a $435 million increase.

Mario Gabelli (Trades, Portfolio) owned 888,700 shares as of Dec. 31, 2014, which accounts for 0.03% of the $15.29 billion portfolio of GAMCO Investors. First Eagle Investment (Trades, Portfolio) owned 5,000 shares as of Dec. 31, 2014, which accounts for 0.0001% of the $40 billion portfolio of First Eagle Investment (Trades, Portfolio).

Intrepid Potash: Exec. Chair, President, CEO, 10% owner Robert P. Jornayvaz III bought 461,614 shares

Intrepid Potash Inc. (IPI, Financial) Exec. Chair, President, CEO and 10% owner Robert P. Jornayvaz III bought 461,614 shares on March 4 at an average price of $1.24. Intrepid Potash was incorporated in Delaware on Nov. 19, 2007, for the purpose of continuing the business of Intrepid Mining LLC. Intrepid Potash has a market cap of $94.430 million; its shares were traded at $1.24 with a P/S ratio of 0.33.

Bruce owned 150,000 shares as of Dec. 31, 2014, which accounts for 0.58% of the $330 million portfolio of Bruce & Co..

Opko Health: CEO, Chairman, 10% owner Phillip Frost, M.D., et al bought 40,900 shares

CEO and Chairman, 10% Owner of Opko Health Inc. (OPK, Financial) Phillip Frost, M.D., et al bought 40,900 shares during the past week at an average price of $10.21. Opko Health was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health has a market cap of $5.57 billion; its shares were traded at $10.21 with a P/S ratio of 10.18. Opko Health had an annual average earnings growth of 11% over the past 10 years.

George Soros (Trades, Portfolio) owned 235,600 shares as of Dec. 31, 2014, which accounts for 0.026% of the $5.38 billion portfolio of Soros Fund Management LLC. Gabelli owned 11,000 shares as of Dec. 31, 2014, which accounts for 0.0006% of the $15.29 billion portfolio of GAMCO Investors.

Seneca Foods: President and CEO, 10% owner Kraig H. Kayser bought 10,080 shares

Seneca Foods Corp. (SENEB, Financial) President and CEO, 10% owner Kraig H. Kayser bought 10,080 shares on March 10 at an average price of $33.50. Seneca Foods is a New York corporation founded in 1949. It has a market cap of $330.769 million; its shares were traded at $33.50 with a P/E ratio of 8.19 a P/S ratio of 0.29.

Seneca Foods recently reported, for the third fiscal quarter of 2016, net earnings of $31.1 million, or $3.10 per diluted share, compared to $7.8 million, or 71 cents per diluted share, in the fiscal third quarter of 2015. Net sales for the third quarter ended Dec. 26, 2015 decreased from the third quarter ended Dec. 27, 2014 by 5.3%, or $24.0 million to $432.2 million.